CureVac N.V. (FRA:5CV)
Germany
· Delayed Price · Currency is EUR 4.392
-0.004 (-0.09%)
At close: Dec 4, 2025
CureVac Market Cap
CureVac has a market cap or net worth of €991.06 million as of December 5, 2025. Its market cap has increased by 81.00% in one year.
Market Cap
991.06M
Enterprise Value
606.77M
Revenue
70.74M
Ranking
n/a
PE Ratio
7.69
Stock Price
€4.39
Market Cap Chart
Since August 14, 2020, CureVac's market cap has decreased from 8.31B to 991.06M, a decrease of -88.08%. That is a compound annual growth rate of -33.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 988.64M | 33.81% |
| Dec 31, 2024 | 738.83M | -13.37% |
| Dec 29, 2023 | 852.88M | -20.54% |
| Dec 30, 2022 | 1.07B | -80.98% |
| Dec 31, 2021 | 5.64B | -51.75% |
| Dec 31, 2020 | 11.69B | 40.67% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Merck KGaA | 52.13B |
| Siemens Healthineers AG | 47.23B |
| Bayer Aktiengesellschaft | 33.65B |
| Fresenius SE & Co. KGaA | 26.69B |
| Sartorius Aktiengesellschaft | 15.89B |
| Fresenius Medical Care AG | 11.57B |
| Carl Zeiss Meditec AG | 3.77B |
| Fielmann Group AG | 3.60B |